This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Discover creative ways to make money fast for teens. Find opportunities that fit your interests and start earning today!
16,949 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
When the S&P 500 posted best quarterly performance, markets flashed a signal that traders will debate for weeks. This...
COLAs are meant to keep your benefits in line with inflation, but many retirees feel the increase doesn’t cover risin...
A political push for a different rate path could reshape markets. This article breaks down what a president donald tr...
U.S. retirees are eyeing Panama’s beach towns as costs rise at home. The question remains: can $600,000 sustain a rel...
A three-week ban on Anthropic's AI services by U.S. regulators ended, igniting a debate over whether the episode coul...
Colorado regulators announced a settlement with Unlock Technologies to reclassify home equity agreements as consumer ...
When a company’s CFO sells shares, investors want to know if it’s a red flag or routine planning. This analysis uses ...
Rising costs and higher rates are pressuring traditional bonds. More retirees replacing bond allocations with dividen...
Nike stock has fallen significantly from its 52-week peak, even as the CEO buys shares. This guide explains what the ...
Crystal Intelligence unveils Crystal AI Analytics, embedding an AI analyst in Crystal Expert to turn on-chain transfe...
A Workday insider recently sold a sizable block of shares. This article breaks down what that signals for investors, ...